Human amniotic membrane-derived epithelial stem cells display anticancer activity in BALB/c female nude mice bearing disseminated breast cancer xenografts

International Journal of Oncology

Volumn 40, Issue 6, 2012, Pages 2022-2028

  Kang, Nam Hee ^a   Yi, B O Rim ^a   Lim, So Yoon ^b   Hwang, Kyung A ^a   Baek, Young Seok ^b   Kang, Kyung Sun ^c   Choi, Kyung Chul ^a  

^a Chungbuk National University   (South Korea)

^b Department of Research and Development   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Amniotic derived epithelial stem cells; Breast cancer; Transplantation; Xenograft

Indexed keywords

COLONY STIMULATING FACTOR 1; FLUOROURACIL; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 8; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN AMNIOTIC MEMBRANE DERIVED EPITHELIAL STEM CELL; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; STEM CELL TRANSPLANTATION; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

AMNION; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYTOKINES; EPITHELIAL CELLS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; STEM CELL TRANSPLANTATION; STEM CELLS; TUMOR BURDEN;

EID: 84861203121     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1372     Document Type: Article

References (29)

1. Anderson LM, Krotz S, Weitzman SA and Thimmapaya B: Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach. Cancer Gene Ther 7: 845-852, 2000. (Pubitemid 30437284)
2. Fidan E, Fidan S, Yildiz B, Durmus I, Kavgaci H, Ozdemir F and Aydin F: Bolus fluorouracil induced syncope and pulseless ventricular tachycardia: a case report. Hippokratia 15: 93-95, 2011.
3. Coley HM: Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev 34: 378-390, 2008.
4. Aboody KS, Najbauer J, Schmidt NO, Yang W, Wu JK, Zhuge Y, Przylecki W, Carroll R, Black PM and Perides G: Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol 8: 119-126, 2006. (Pubitemid 46542656)
5. Ayuzawa R, Doi C, Rachakatla RS, Pyle MM, Maurya DK, Troyer D and Tamura M: Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett 280: 31-37, 2009.
6. Cho JA, Park H, Kim HK, Lim EH, Seo SW, Choi JS and Lee KW: Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line. Cancer 115: 311-323, 2009.
7. Gardner SL: Application of stem cell transplant for brain tumors. Pediatr Transplant 8 (Suppl 5): 28-32, 2004.
8. Klopp AH, Gupta A, Spaeth E, Andreeff M and Marini F III: Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29: 11-19, 2011.
9. Zhang D, Jiang M and Miao D: Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse. PLoS One 6: e16789, 2011.
10. Zhang X, Chen X, Wang H and Liu S: Development of amniotic fluid-derived stem cell. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22: 864-868, 2008.
11. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, Nguyen AT, Malide D, Combs CA, Hall G, Zhang J, Raffeld M, Rogers TB, Stetler-Stevenson W, Frank JA, Reitz M and Finkel T: Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 203: 1235-1247, 2006. (Pubitemid 43736593)
12. Dobreva MP, Pereira PN, Deprest J and Zwijsen A: On the origin of amniotic stem cells: of mice and men. Int J Dev Biol 54: 761-777, 2010.
13. Kakishita K, Nakao N, Sakuragawa N and Itakura T: Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res 980: 48-56, 2003. (Pubitemid 36836114)
14. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, Cho DJ, Kang SG and You J: Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 40: 75-90, 2007. (Pubitemid 46103692)
15. Yi BR, Kang NH, Hwang KA, Kim SU, Jeung EB and Choi KC: Antitumor therapeutic effects of cytosine deaminase and interferon-beta against endometrial cancer cells using genetically engineered stem cells in vitro. Anticancer Res 31: 2853-2861, 2011.
16. Yi BR, O SN, Kang NH, Hwang KA, Kim SU, Jeung EB, Kim YB, Heo GJ and Choi KC: Genetically engineered stem cells expressing cytosine deaminase and interferon-β migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects. Int J Oncol 39: 833-839, 2011.
17. Iankov ID, Msaouel P, Allen C, Federspiel MJ, Bulur PA, Dietz AB, Gastineau D, Ikeda Y, Ingle JN, Russell SJ and Galanis E: Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model. Breast Cancer Res Treat 122: 745-754, 2010.
18. Koskimaki JE, Karagiannis ED, Rosca EV, Vesuna F, Winnard PT Jr, Raman V, Bhujwalla ZM and Popel AS: Peptides derived from type IV collagen, CXC chemokines, and thrombospondin- 1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts. Neoplasia 11: 1285-1291, 2009.
19. Peterson SM, Iskenderian A, Cook L, Romashko A, Tobin K, Jones M, Norton A, Gomez-Yafal A, Heartlein MW, Concino MF, Liaw L and Martini PG: Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts. BMC Cancer 10: 427, 2010.
20. Roland CL, Lynn KD, Toombs JE, Dineen SP, Udugamasooriya DG and Brekken RA: Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer. PLoS One 4: e7669, 2009.
21. Aboody KS, Bush RA, Garcia E, Metz MZ, Najbauer J, Justus KA, Phelps DA, Remack JS, Yoon KJ, Gillespie S, Kim SU, Glackin CA, Potter PM and Danks MK: Development of a tumor-selective approach to treat metastatic cancer. PLoS One 1: e23, 2006.
22. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ and Andreeff M: Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62: 3603-3608, 2002. (Pubitemid 34728832)
23. Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon LG, Black PM and Carroll RS: Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 12: 5550-5556, 2006. (Pubitemid 44497273)
24. Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK, Phi JH, Park IH, Black PM, Carroll RS, Lee J and Kim SK: Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clin Cancer Res 15: 4925-4934, 2009.
25. Rachakatla RS, Marini F, Weiss ML, Tamura M and Troyer D: Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther 14: 828-835, 2007. (Pubitemid 47402382)
26. Rachakatla RS, Pyle MM, Ayuzawa R, Edwards SM, Marini FC, Weiss ML, Tamura M and Troyer D: Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs. Cancer Invest 26: 662-670, 2008.
27. Secchiero P, Zorzet S, Tripodo C, Corallini F, Melloni E, Caruso L, Bosco R, Ingrao S, Zavan B and Zauli G: Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. PLoS One 5: e11140, 2010.
28. Kucerova L, Altanerova V, Matuskova M, Tyciakova S and Altaner C: Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 67: 6304-6313, 2007. (Pubitemid 47037513)
29. Larmonier N, Ghiringhelli F, Larmonier CB, Moutet M, Fromentin A, Baulot E, Solary E, Bonnotte B and Martin F: Freshly isolated bone marrow cells induce death of various carcinoma cell lines. Int J Cancer 107: 747-756, 2003. (Pubitemid 37339728)